Long COVID Support Act Contains Language YOU Fought For!
Last month, Senators Tim Kaine (D-VA) and Todd Young (R-IN) introduced the bipartisan Long COVID Support Act to accelerate Long Covid research and provide relevant information to patients and medical […]
Thank You for Another Spectacular Advocacy Week!
It was so incredible seeing members of our community at Advocacy Week last month — both in person and virtually! Thank you so much for the energy and time you […]
Solve Brings Army of Advocates to Capitol Hill, Presses Congress to Support the Care for Long Covid Act
Advocacy Week 2023 unites Long Covid, ME/CFS communities in an effort to educate congressional representatives, marking the first in-person gathering for the event since 2019. LOS ANGELES, CA – Today […]
Ask Congress to CARE!
We’re excited to announce our House and Senate asks for Solve M.E.’s Advocacy Week 2023! The two pieces of legislation are companion pieces to one another — we will be […]
Sen. Tim Kaine Shares His Long Covid Experience at Solve Event, Calls for More Research and Equitable Care
Solve recently co-hosted with BIO the event “Long Covid: What Will It Take to Accelerate Therapeutic Progress?,” convening stakeholders to advance research and development to diagnose and treat Long Covid, […]
Key Takeaways from the New Federal Budget
Dear advocates, allies, and friends: I’d like to take one last look back at 2022 before we leap forward into an exciting new year. Starting with the Omnibus Appropriations bill, […]
Solve M.E. Board Member Testifies at Congressional Hearing
House Holds Hearing on “Understanding and Addressing Long Covid” This week, the Select Subcommittee on the Coronavirus Crisis held a hearing on understanding and addressing Long Covid and its consequences. […]
Ask Congress to TREAT & CARE for Post-Infection Diseases During Advocacy Month
Advocacy Month is an opportunity to share the policy solutions vital to address the growing number of individuals suffering from ME/CFS and Long Covid. ME/CFS devastated the lives of an […]
